Hayotte Aurélie, Mariani-Kurkdjian Patricia, Boizeau Priscilla, Dauger Stéphane, Riaud Charline, Lacarra Boris, Bourmaud Aurélie, Levy Michael
Pediatric Intensive Care Unit, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, 75019 Paris, France.
Université Paris Cité, 75006 Paris, France.
Microorganisms. 2023 Mar 29;11(4):884. doi: 10.3390/microorganisms11040884.
PCR tests for viral identification, performed on nasopharyngeal secretions, have experienced a major boom in the last few years. Their use is very frequent, but their indications are still not well defined, especially in Paediatric Intensive Care Units (PICU). These tests are used for the microbiological diagnosis of lower respiratory infections but can be used in other situations. The aim of the study was to investigate the effect of viral identification on antibiotic therapy management. We conducted a single-centre retrospective study from 1 October 2017 to 31 December 2019. This study included all consecutive FilmArray Respiratory Panel tests performed in patients hospitalised in a PICU. Patients were identified using the microbiology laboratory prospective database and data were extracted from the medical record. 544 tests corresponding to 408 patients were included. The main reasons for testing were pneumonia (34%) and bronchiolitis (24%). In 70% of cases, at least one virus was identified, with Human Rhinovirus (56%) and Respiratory Syncytial Virus (28%) being the two predominant. Bacterial co-infection was present in 25% of cases. Viral identification was not associated with reduced antibiotic therapy. On multivariate analysis, antibiotic management was significantly associated with clinical gravity, CRP value or radiology findings regardless of virus identification. Viral identification has an epidemiological value, but antibiotic prescription relies on other factors.
对鼻咽分泌物进行的用于病毒鉴定的聚合酶链反应(PCR)检测在过去几年中经历了大幅增长。它们的使用非常频繁,但其适用指征仍未明确界定,尤其是在儿科重症监护病房(PICU)。这些检测用于下呼吸道感染的微生物学诊断,但也可用于其他情况。本研究的目的是调查病毒鉴定对抗生素治疗管理的影响。我们进行了一项单中心回顾性研究,时间跨度为2017年10月1日至2019年12月31日。该研究纳入了在PICU住院患者中进行的所有连续的FilmArray呼吸道检测板检测。通过微生物实验室前瞻性数据库识别患者,并从病历中提取数据。共纳入了对应408例患者的544次检测。检测的主要原因是肺炎(占比34%)和细支气管炎(占比24%)。在70%的病例中,至少鉴定出一种病毒,其中人鼻病毒(占比56%)和呼吸道合胞病毒(占比28%)是两种主要病毒。25%的病例存在细菌合并感染。病毒鉴定与抗生素治疗的减少无关。在多变量分析中,无论病毒鉴定结果如何,抗生素管理与临床严重程度、CRP值或影像学检查结果显著相关。病毒鉴定具有流行病学价值,但抗生素处方依赖于其他因素。